Clinical Trials on Head Cancer Neck in New Zealand
Total 8159 results
-
ExelixisActive, not recruitingA Study of XL092 as Single-Agent and Combination Therapy in Subjects With Solid Tumors (STELLAR-001)Renal Cell Carcinoma | Colorectal Cancer | Metastatic Castration-resistant Prostate Cancer | Hormone Receptor Positive Breast Carcinoma | Neoplasm MalignantUnited States, Australia, Belgium, Czechia, France, Germany, Italy, Netherlands, Spain, United Kingdom
-
National Cancer Institute (NCI)RecruitingAnal Canal Cloacogenic Carcinoma | Metastatic Anal Squamous Cell Carcinoma | Recurrent Anal Squamous Cell Carcinoma | Stage III Anal Cancer AJCC v8 | Stage IV Anal Cancer AJCC v8 | Unresectable Anal Squamous Cell Carcinoma | Anal Basaloid Squamous Cell CarcinomaUnited States
-
Genentech, Inc.Completed
-
Queen Mary University of LondonCompletedBreast CancerIreland, United Kingdom, Switzerland, Australia, Belgium, Chile, Denmark, Finland, Germany, Hungary, Italy, Malta, Portugal, Turkey
-
Incyte CorporationMerck Sharp & Dohme LLCCompletedUC (Urothelial Cancer)United States, Spain, Hungary, Israel, United Kingdom, Korea, Republic of, Taiwan, Denmark, France, Netherlands, Italy, Canada, Japan, Turkey, Germany, Ireland, Australia, Russian Federation
-
Summit TherapeuticsAkesoRecruitingNon-Squamous Non-small Cell Lung CancerCanada, United States, Spain, Italy, France, United Kingdom
-
AstraZenecaMerck Sharp & Dohme LLC; Myriad Genetics, Inc.; Foundation Medicine, Inc.CompletedMetastatic Castration-resistant Prostate CancerUnited States, Canada, Denmark, Germany, Italy, Netherlands, Norway, Spain, Argentina, Taiwan, France, Korea, Republic of, Brazil, Japan, Turkey, United Kingdom, Austria, Australia, Israel, Sweden
-
AstraZenecaDaiichi SankyoRecruitingAdvanced or Metastatic NSCLCUnited States, Taiwan, Italy, Poland, Spain, Japan, Belgium, Turkey, France, Korea, Republic of
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedBreast Cancer | OsteoporosisUnited States
-
Nykode Therapeutics ASARoche Pharma AG; GOG FoundationRecruitingCervical Cancer | HPV-Related Malignancy | HPV-Related Cervical CarcinomaUnited States
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); NRG OncologyCompletedLung Cancer | Radiation Toxicity | Oral Complications | Drug/Agent Toxicity by Tissue/OrganUnited States, Canada
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedCervical Carcinoma | Cervical Intraepithelial Neoplasia Grade 2/3 | Stage 0 Cervical CancerUnited States
-
AstraZenecaMyriad Genetic Laboratories, Inc.WithdrawnPlatinum Sensitive Relapsed Ovarian CancerUnited States, Korea, Republic of, Peru, United Kingdom, Philippines
-
AstraZenecaActive, not recruitingLocally Advanced or Metastatic Non Small Cell Lung Cancer Stage IIIb - IVUnited States, Canada, France, Italy, Spain, United Kingdom, Belgium, Poland, Brazil, Germany, Hungary, Peru, Russian Federation, Turkey, Australia, Chile, Austria, Netherlands, Portugal, Israel, Mexico, Romania, Sweden, Ukraine, Bulgaria, Argenti...
-
Canadian Cancer Trials GroupCanadian Cancer Clinical Trials NetworkRecruitingEndometrial CancerCanada, Australia, Netherlands
-
MedImmune LLCCompletedKidney Cancer | Clear Cell Renal Cell Carcinoma | Select Advanced MalignanciesUnited States, France, Canada, United Kingdom, Netherlands, Australia
-
SanofiTerminatedBreast CancerUnited States, Russian Federation, Italy, Australia, Belgium, France, Japan, Ukraine, Netherlands, Argentina, Canada, Portugal, Spain, Austria, Brazil, Bulgaria, Chile, China, Czechia, Finland, Georgia, Germany, Hungary, Korea, Republic... and more
-
NSABP Foundation IncNational Cancer Institute (NCI); NovartisActive, not recruitingBreast CancerUnited States, Canada, Ireland
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
National Cancer Institute (NCI)Not yet recruitingNon-Muscle Invasive Bladder Urothelial Carcinoma | Recurrent Non-Muscle Invasive Bladder Urothelial CarcinomaUnited States
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)TerminatedHigh Grade Squamous Intraepithelial Neoplasia | Stage 0 Uterine Corpus CancerUnited States
-
PfizerCompletedMelanoma and Metastatic Colorectal CancerUnited States, Spain, France, Japan, Australia, Switzerland, Norway
-
University of Texas Southwestern Medical CenterNational Cancer Institute (NCI); Baylor College of Medicine; University of Pennsylvania and other collaboratorsRecruitingLiver Cirrhosis | Hepatitis B | Carcinoma, Hepatocellular | Liver CancerUnited States
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingPancreatic Adenocarcinoma | Pancreatic Ductal Adenocarcinoma | Pancreatic Intraductal Papillary-Mucinous Neoplasm | Stage I Pancreatic Cancer AJCC v6 and v7 | Stage II Pancreatic Cancer AJCC v6 and v7United States, Canada, Israel, Belgium
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyActive, not recruitingNon-small Cell Lung CancerKorea, Republic of, Taiwan, United States, China, Hong Kong, France, Russian Federation, Netherlands, Japan, Spain, Italy, Belgium, Vietnam, Malaysia, Thailand, Germany, Singapore
-
MeiraGTx, LLCRecruitingGrade 2 and 3 Late Xerostomia Caused by Radiotherapy for Cancers of the Upper Aerodigestive Tract, Excluding the Parotid GlandsUnited States, Canada
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingHereditary Breast and Ovarian Cancer Syndrome | Premenopausal | Deleterious BARD1 Gene Mutation | Deleterious BRCA1 Gene Mutation | Deleterious BRCA2 Gene Mutation | Deleterious BRIP1 Gene Mutation | Deleterious EPCAM Gene Mutation | Deleterious MLH1 Gene Mutation | Deleterious MSH2 Gene Mutation | Deleterious... and other conditionsUnited States
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)TerminatedVulvar CancerUnited States, Canada
-
Incyte CorporationTerminatedNSCLC (Non-small Cell Lung Carcinoma)United States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedGallbladder CancerUnited States, Canada
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdRecruitingMetastatic Colorectal CancerUnited States, Belgium, China, Canada, Denmark, France, Norway, Romania, Spain, United Kingdom, Austria, Brazil, Germany, Netherlands, Argentina, Czechia, Ireland, Italy, Turkey, Chile, Greece, Puerto Rico, Australia, Japan
-
Gilead SciencesArcus Biosciences, Inc.RecruitingNon-small Cell Lung CancerTaiwan, Hong Kong, United States, Netherlands, United Kingdom, Italy, Korea, Republic of, Spain, Israel, Japan, France, Portugal, China, Turkey, Brazil, Mexico, Austria, Germany, Belgium, Chile, Argentina, Singapore, Canada
-
Astellas Pharma Global Development, Inc.Seagen Inc.RecruitingCarcinoma in Situ | Urinary Bladder Neoplasms | Non-muscle Invasive Bladder Cancer | Carcinoma Transitional Cell | NMIBCUnited States, Canada, France, Spain, United Kingdom, Germany
-
AstraZenecaRecruitingMuscle Invasive Bladder CancerNetherlands, United Kingdom, Korea, Republic of, Canada, Germany, Italy, Poland, Spain, Turkey, Vietnam, Argentina, Japan, France, Brazil, Taiwan, United States, Israel, Austria, Chile, Colombia, Greece, Hong Kong, Mexico, Portugal, Russian... and more
-
National Cancer Institute (NCI)Active, not recruitingMetastatic Renal Cell Carcinoma | Stage III Renal Cell Cancer AJCC v8 | Stage IV Renal Cell Cancer AJCC v8 | Unresectable Renal Cell Carcinoma | TFE3-Rearranged Renal Cell CarcinomaUnited States, Puerto Rico
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)Active, not recruitingS0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast CancerBreast CancerUnited States, Puerto Rico, Canada
-
AbbVieTerminatedSmall Cell Lung CancerUnited States, Australia, Austria, Belarus, Belgium, Brazil, Bulgaria, Canada, China, Croatia, Czechia, Denmark, Estonia, Finland, France, Germany, Greece, Hong Kong, Hungary, Ireland, Israel, Italy, Japan, Korea, Republic of, Latvia, Lit... and more
-
National Hospital Organization Nagoya Medical CenterRecruitingAcute Lymphoblastic Leukemia | Down Syndrome | Childhood CancerTaiwan, Thailand, Hong Kong, Singapore, Malaysia, Japan
-
Columbia UniversityInternational Agency for Research on CancerRecruitingAcute Lymphoblastic Leukemia | Nutrition Aspect of Cancer | Genetic Predisposition | MicrotiaUnited States, Guatemala, Brazil, Honduras, India, Tanzania
-
UroGen Pharma Ltd.Active, not recruitingBladder Cancer | Urothelial Carcinoma Bladder | Urothelial CarcinomaUnited States, Spain, Lithuania, Georgia, Bulgaria, Estonia, Latvia, Poland, Serbia, Austria
-
Southwest Oncology GroupNational Cancer Institute (NCI); National Center for Complementary and Integrative...CompletedPain | Breast CancerUnited States
-
Eisai Inc.Eisai LimitedCompletedBreast CancerUnited States, Canada
-
Mateon TherapeuticsTerminatedPlatinum Resistant Ovarian CancerUnited States, Belgium, Germany
-
Bristol-Myers SquibbCompletedLiver CancerUnited States, Argentina, Brazil, Canada, China, France, Germany, Hong Kong, India, Italy, Japan, Korea, Republic of, Mexico, Puerto Rico, Russian Federation, Taiwan, Spain, Belgium, Greece
-
Helsinn Therapeutics (U.S.), IncCompletedNon-Small Cell Lung Cancer | CachexiaPoland, Ukraine, United States, Belgium, Spain, Belarus, Slovenia, Serbia, Canada, Russian Federation, Australia, Hungary, Germany, Czechia, France, Israel, Italy
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedBreast CarcinomaUnited States
-
Spectrum Pharmaceuticals, IncCompletedBreast Cancer | NeutropeniaUnited States, Canada, Korea, Republic of
-
Novartis PharmaceuticalsCompletedNon-Small Cell Lung CancerCanada, Taiwan, United States, Italy, Korea, Republic of, Thailand, Belgium, Germany, Austria, Turkey, Greece, United Kingdom, Colombia, India, Malaysia, Brazil, Spain, Poland, Bulgaria, Australia, Czechia, Lebanon, Netherlands, Russian...
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedLung CancerUnited States
-
GlaxoSmithKlineCompletedOvarian CancerUnited States